Skip to main content
. 2015 Jul 7;10(3):1207–1211. doi: 10.3892/etm.2015.2622

Figure 1.

Figure 1.

Values of (A) brachial artery flow-mediated dilation (FMD), and the (B) pulse wave velocity (PWV) and (C) β-stiffness of the common carotid artery at the beginning (day 0; white columns) and at the end (day 30, shaded columns) of current treatment and initial treatment in the control group (received placebo for 30 days) and the treatment group (received a combination of 10 mg fluvastatin and 20 mg valsartan daily for 30 days). * P<0.05 vs. the control group.